Valuation: Treace Medical Concepts, Inc.

Market Cap 278M 248M 229M 208M 388M 26.36B 395M 2.76B 1.09B 13.81B 1.04B 1.02B 43.54B P/E 2026 *
-5.02x
P/E 2027 * -5.51x
Enterprise Value 323M 289M 267M 242M 452M 30.7B 460M 3.21B 1.27B 16.08B 1.21B 1.19B 50.71B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.64x
Free-Float
74.47%
Yield 2026 *
-
Yield 2027 * -
1 day-0.23%
1 week+10.34%
Current month-3.83%
1 month-5.95%
3 months+6.75%
6 months+115.66%
Current year+74.29%
1 week 3.82
Extreme 3.825
4.3
1 month 3.78
Extreme 3.78
4.63
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
6.92
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
27.97
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2013
Director of Finance/CFO 56 01/09/2020
Chief Tech/Sci/R&D Officer - 01/03/2022
Director TitleAgeSince
Chairman 54 20/05/2025
Director/Board Member 65 20/11/2020
Director/Board Member 68 20/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 A Tax

Compliance Officer

-25,457 0.0391%
8/24/26 A Buy

Chief Executive Officer

11,000 0.0170%
8/9/26 A Tax

Chief Financial Officer

-37,102 0.0572%
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%+10.34%-37.85%-56.65% 278M
+1.16%-1.13%-18.25%+9.38% 179B
+0.02%+4.24%-19.55%+15.88% 118B
-1.22%+0.70%+1.86%+32.59% 117B
+2.29%+17.36%-42.18%+8.22% 93.26B
-2.21%-2.91%-0.51%+75.12% 63.16B
-1.06%+1.75%+13.48%+74.12% 55.68B
-0.75%+3.73%+7.04%-23.26% 54.18B
-1.13%+0.00%-12.56%+30.09% 44.15B
+0.17%+5.85%-5.20%-11.43% 33.95B
Average -0.30%+4.28%-11.37%+15.40% 75.87B
Weighted average by Cap. -0.00%+3.09%-11.78%+21.96%

Financials

2026 *2027 *
Net sales 207M 185M 171M 155M 290M 19.69B 295M 2.06B 815M 10.32B 779M 762M 32.53B 222M 198M 183M 166M 310M 21.05B 315M 2.2B 871M 11.03B 832M 814M 34.77B
Net income -55.26M -49.35M -45.59M -41.32M -77.3M -5.25B -78.58M -549M -217M -2.75B -207M -203M -8.67B -51.01M -45.55M -42.08M -38.14M -71.35M -4.84B -72.53M -506M -200M -2.54B -191M -187M -8B
Net Debt 45.67M 40.78M 37.67M 34.14M 63.87M 4.34B 64.93M 453M 179M 2.27B 171M 168M 7.16B 86.44M 77.19M 71.31M 64.62M 121M 8.21B 123M 858M 340M 4.3B 324M 317M 13.55B
Projected Income Statement - Annual - Treace Medical Concepts, Inc.
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
23/10/26 $4.270 -0.23% 213,110
22/10/26 $4.280 +3.38% 250,321
21/10/26 $4.140 +1.72% 196,643
20/10/26 $4.070 +4.90% 184,223
19/10/26 $3.880 +0.26% 144,290
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Treace Medical Concepts, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.270USD
Average target price
5.500USD
Spread / Average Target
+28.81%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Treace Medical Concepts, Inc.
  1. Stock Market
  2. Stocks
  3. TMCI Stock